Stryker Corporation (SYK)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Stryker Corporation (SYK)
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Key Insights
Critical company metrics and information
Share Price
$381.45Market Cap
$145.41 BillionTotal Outstanding Shares
381.22 Million SharesTotal Employees
52,000Dividend
$0.8 Per Share QuarterlyIPO Date
February 1, 1988SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.stryker.com
Historical Stock Splits
If you bought 1 share of SYK before May 17, 2004, you'd have 2 shares today.
Execution Date | Split Amount |
---|---|
May 17, 2004 | 2-for-1 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $983.00 Million |
Net Cash Flow | $1.99 Billion |
Net Cash Flow From Financing Activities | $983.00 Million |
Net Cash Flow From Investing Activities, Continuing | $-2.85 Billion |
Net Cash Flow From Operating Activities, Continuing | $3.84 Billion |
Exchange Gains/Losses | $17.00 Million |
Net Cash Flow From Operating Activities | $3.84 Billion |
Net Cash Flow From Investing Activities | $-2.85 Billion |
Net Cash Flow, Continuing | $1.97 Billion |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Operating Expenses | $634.00 Million |
Nonoperating Income/Loss | $-175.00 Million |
Net Income/Loss Available To Common Stockholders, Basic | $3.59 Billion |
Costs And Expenses | $17.78 Billion |
Operating Expenses | $9.63 Billion |
Diluted Average Shares | $385.40 Million |
Basic Average Shares | $381.00 Million |
Research and Development | $1.46 Billion |
Operating Income/Loss | $4.33 Billion |
Revenues | $21.97 Billion |
Net Income/Loss | $3.59 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income Tax Expense/Benefit | $600.00 Million |
Income Tax Expense/Benefit, Deferred | $-223.00 Million |
Cost Of Revenue | $8.01 Billion |
Net Income/Loss Attributable To Parent | $3.59 Billion |
Benefits Costs and Expenses | $17.78 Billion |
Selling, General, and Administrative Expenses | $7.51 Billion |
Income/Loss From Continuing Operations Before Tax | $4.19 Billion |
Diluted Earnings Per Share | $9.33 |
Gross Profit | $13.97 Billion |
Basic Earnings Per Share | $9.43 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Income/Loss From Continuing Operations After Tax | $3.67 Billion |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Non-current Assets | $20.79 Billion |
Noncurrent Assets | $29.16 Billion |
Equity | $20.15 Billion |
Current Liabilities | $7.67 Billion |
Noncurrent Liabilities | $16.02 Billion |
Current Assets | $14.67 Billion |
Other Current Liabilities | $6.42 Billion |
Other Current Assets | $8.42 Billion |
Inventory | $5.29 Billion |
Wages | $1.25 Billion |
Intangible Assets | $4.94 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Equity Attributable To Parent | $20.15 Billion |
Liabilities And Equity | $43.83 Billion |
Liabilities | $23.68 Billion |
Fixed Assets | $3.43 Billion |
Assets | $43.83 Billion |
Prepaid Expenses | $961.00 Million |
Historical Dividends
Current dividend: $0.8 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Aug 7, 2024 | Oct 31, 2024 | Sep 30, 2024 | $0.8 | Quarterly |
May 9, 2024 | Jul 31, 2024 | Jun 28, 2024 | $0.8 | Quarterly |
Feb 7, 2024 | Apr 30, 2024 | Mar 29, 2024 | $0.8 | Quarterly |
Dec 5, 2023 | Jan 31, 2024 | Dec 29, 2023 | $0.8 | Quarterly |
Aug 2, 2023 | Oct 31, 2023 | Sep 29, 2023 | $0.75 | Quarterly |
May 10, 2023 | Jul 31, 2023 | Jun 30, 2023 | $0.75 | Quarterly |
Feb 9, 2023 | Apr 28, 2023 | Mar 31, 2023 | $0.75 | Quarterly |
Dec 7, 2022 | Jan 31, 2023 | Dec 30, 2022 | $0.75 | Quarterly |
Aug 3, 2022 | Oct 31, 2022 | Sep 30, 2022 | $0.695 | Quarterly |
May 4, 2022 | Jul 29, 2022 | Jun 30, 2022 | $0.695 | Quarterly |
Feb 2, 2022 | Apr 29, 2022 | Mar 31, 2022 | $0.695 | Quarterly |
Dec 9, 2021 | Jan 31, 2022 | Dec 31, 2021 | $0.695 | Quarterly |
Aug 4, 2021 | Oct 29, 2021 | Sep 30, 2021 | $0.63 | Quarterly |
May 4, 2021 | Jul 30, 2021 | Jun 30, 2021 | $0.63 | Quarterly |
Feb 2, 2021 | Apr 30, 2021 | Mar 31, 2021 | $0.63 | Quarterly |
Dec 2, 2020 | Jan 29, 2021 | Dec 31, 2020 | $0.63 | Quarterly |
Jul 30, 2020 | Oct 30, 2020 | Sep 30, 2020 | $0.575 | Quarterly |
May 5, 2020 | Jul 31, 2020 | Jun 30, 2020 | $0.575 | Quarterly |
Feb 5, 2020 | Apr 30, 2020 | Mar 31, 2020 | $0.575 | Quarterly |
Dec 4, 2019 | Jan 31, 2020 | Dec 31, 2019 | $0.575 | Quarterly |
Jul 31, 2019 | Oct 31, 2019 | Sep 30, 2019 | $0.52 | Quarterly |
May 1, 2019 | Jul 31, 2019 | Jun 28, 2019 | $0.52 | Quarterly |
Feb 6, 2019 | Apr 30, 2019 | Mar 29, 2019 | $0.52 | Quarterly |
Dec 4, 2018 | Jan 31, 2019 | Dec 31, 2018 | $0.52 | Quarterly |
May 2, 2018 | Jul 31, 2018 | Jun 29, 2018 | $0.47 | Quarterly |
Feb 7, 2018 | Apr 30, 2018 | Mar 29, 2018 | $0.47 | Quarterly |
Dec 6, 2017 | Jan 31, 2018 | Dec 29, 2017 | $0.47 | Quarterly |
Aug 1, 2017 | Oct 31, 2017 | Sep 29, 2017 | $0.425 | Quarterly |
May 2, 2017 | Jul 31, 2017 | Jun 30, 2017 | $0.425 | Quarterly |
Feb 8, 2017 | Apr 28, 2017 | Mar 31, 2017 | $0.425 | Quarterly |
Dec 7, 2016 | Jan 31, 2017 | Dec 30, 2016 | $0.425 | Quarterly |
Jul 27, 2016 | Oct 31, 2016 | Sep 30, 2016 | $0.38 | Quarterly |
Apr 29, 2015 | Jul 31, 2015 | Jun 30, 2015 | $0.345 | Quarterly |
Feb 10, 2015 | Apr 30, 2015 | Mar 31, 2015 | $0.345 | Quarterly |
Dec 3, 2014 | Jan 30, 2015 | Dec 31, 2014 | $0.345 | Quarterly |
Jul 21, 2014 | Oct 31, 2014 | Sep 30, 2014 | $0.305 | Quarterly |
Apr 22, 2014 | Jul 31, 2014 | Jun 30, 2014 | $0.305 | Quarterly |
Feb 12, 2014 | Apr 30, 2014 | Mar 31, 2014 | $0.305 | Quarterly |
Dec 4, 2013 | Jan 31, 2014 | Dec 31, 2013 | $0.305 | Quarterly |
Jul 25, 2013 | Oct 31, 2013 | Sep 30, 2013 | $0.265 | Quarterly |
Apr 30, 2013 | Jul 31, 2013 | Jun 28, 2013 | $0.265 | Quarterly |
Feb 14, 2013 | Apr 30, 2013 | Mar 28, 2013 | $0.265 | Quarterly |
Dec 5, 2012 | Jan 31, 2013 | Dec 31, 2012 | $0.265 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Stryker Corporation (SYK)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.